相关实验视频

Updated: Jul 5, 2025

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

MRN-100的抗辐射作用:一种水合铁酸盐液体,体内

Mamdooh Ghoneum^1,2, Nariman K Badr El-Din³, Mai Alaa El-Dein³

¹Department of Surgery, Charles Drew University of Medicine and Science, 1621 East 120th Street, Los Angeles, California 90059, USA.

Journal of radiation research

|January 22, 2024

概括

MRN-100是一种酸盐液体,通过减少氧化应激和改善血液计数来保护小鼠免受辐射损伤. 这种营养药物显示为减轻辐射引起的器官损伤的辅助疗法.

科学领域:

放射学放射学是一门学科.
生物化学生物化学
血液学血液学血液学

背景情况:

电离辐射 (IR) 会对器官造成重大损伤,尤其是造血组织组织.
开发有效的保护性营养药物对IR至关重要.
MRN-100是一种酸盐液体,此前已经在鱼类中证明了辐射保护作用.

研究的目的:

评估MRN-100对小鼠辐射暴露的保护效果.
阐明MRN-100辐射保护作用的潜在机制.

主要方法:

小鼠接受了5 Gy的全身X射线照射剂量.
在辐射前2周到辐射后1周的时间内,MRN-100被给予.
分析包括氧化应激标志物,血液学参数,DNA损伤,肝酶和脏组织学.

主要成果:

MRN-100改善了辐射诱导的全血细胞计 (CBC) 参数的下降,并防止DNA损伤.
它增强了抗氧化能力,增加了谷氨,超氧化物转化酶和催化酶水平.
MRN-100减少了氧化应激生物标志物,并在组织学上保护了脏组织.

结论:

在小鼠中,MRN-100的消耗有效地抵消了辐射诱导的氧化应激和血液学损伤.
MRN-100显示出作为辅助疗法的潜力,以防止辐射诱导的器官损伤.

关键词:

这是一种8-OHdG.造成的DNA损伤是DNA损伤.这是一个MRN-100号.抗氧化剂是一种抗氧化剂.血液学血液学血液学组织病理学组织病理学辐射辐射辐射辐射的辐射

更多相关视频

Noninvasive In Vivo Small Animal MRI and MRS: Basic Experimental Procedures

Noninvasive In Vivo Small Animal MRI and MRS: Basic Experimental Procedures

Published on: October 20, 2009

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy

Published on: August 28, 2013

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...